Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study

Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response

(2017) Omar Elsherif et al.   PLoS One

Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy

(2016) D. Banerjee et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

(2016) Mark S. Sulkowski et al.   GASTROENTEROLOGY

Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System

(2016) George N. Ioannou et al.   GASTROENTEROLOGY

HCV epidemiology in high-risk groups and the risk of reinfection

(2016) Håvard Midgard et al.   JOURNAL OF HEPATOLOGY

Hepatitis C reinfection after sustained virological response

(2016) Håvard Midgard et al.   JOURNAL OF HEPATOLOGY

Deep sequencing of hepatitis C virus reveals genetic compartmentalization in cerebrospinal fluid from cognitively impaired patients

(2016) Damien C. Tully et al.   LIVER INTERNATIONAL

Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens

(2015) Z. Younossi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Psychiatric Care During Hepatitis C Treatment: The Changing Role of Psychiatrists in the Era of Direct-Acting Antivirals

(2015) Sanjeev Sockalingam et al.   AMERICAN JOURNAL OF PSYCHIATRY

The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B

(2015) N. Coppola et al.   CLINICAL MICROBIOLOGY AND INFECTION

The safety of daclatasvir for the treatment of hepatitis C

(2015) Syed-Mohammed Jafri et al.   Expert Opinion On Drug Safety

Extrahepatic Morbidity and Mortality of Chronic Hepatitis C

(2015) Francesco Negro et al.   GASTROENTEROLOGY

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections

(2015) Barbara Rehermann et al.   HEPATOLOGY

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

(2015) Zobair M. Younossi et al.   HEPATOLOGY

Interferon-free, direct-acting antiviral therapy for chronic hepatitis C

(2015) J. A. Gutierrez et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis B virus burden in developing countries

(2015) Rosa Zampino   WORLD JOURNAL OF GASTROENTEROLOGY

Factors influencing adherence in Hepatitis-C infected patients: a systematic review

(2014) Tim Mathes et al.   BMC INFECTIOUS DISEASES

Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation

(2014) Carolina Hoyo-Becerra et al.   BRAIN BEHAVIOR AND IMMUNITY

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study

(2014) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

(2014) Eric Lawitz et al.   LANCET

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3

(2014) Claus Niederau et al.   PLoS One

An empirical study of alcohol consumption by patients considering HCV treatment

(2014) Carol S. North et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C

(2013) Michael R. Kraus et al.   HEPATOLOGY

Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement

(2012) Martin Schaefer et al.   JOURNAL OF HEPATOLOGY

Agreement between physicians' and patients' ratings on the Montgomery–Åsberg Depression Rating Scale

(2011) Janet L. Cunningham et al.   JOURNAL OF AFFECTIVE DISORDERS

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

(2011)   JOURNAL OF HEPATOLOGY

Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition

(2011) Valerie Byrnes et al.   JOURNAL OF HEPATOLOGY

Antiviral Completion Rates and Sustained Viral Response in Hepatitis C Patients With and Without Preexisting Major Depressive Disorder

(2011) Peter Hauser et al.   PSYCHOSOMATICS

The self-reported Montgomery-Åsberg depression rating scale is a useful evaluative tool in major depressive disorder

(2009) Bruno Fantino et al.   BMC Psychiatry

A Review of Sleep Disturbance in Hepatitis C

(2009) Sanjeev Sockalingam et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY